The British journal of radiology · 2026
Automated segmentation of complicated cystic renal masses using 3D V-Net convolutional neural network on MRI.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kang Huanhuan, Jia Chuang, Wang Zhongyi, Huang Bin, Wang He, Jiang Jiahui, Liu Zhe, Cui Mengqiu, Zhao Jian, Bai Xu, Li Lin, Guo Huiping, Ning Xueyi, Ye Huiyi, Yang Dawei, Guo Hao, Xue Jian, Wang Haiyi
Аннотация
OBJECTIVES: To develop and test a convolutional neural network model for automated segmentation of complicated cystic renal masses (cCRMs) on MRI.
METHODS: This multicenter retrospective study analysed 210 cCRMs between October 2019 and May 2021, divided into training/internal validation (n = 150, Institution 1) and test sets (n = 60, Institutions 2-4). Comparative 3D V-Net and U-Net models were developed across 7 MRI sequences (T2-weighted, diffusion-weighted, apparent diffusion coefficient maps, unenhanced T1-weighted, and enhanced corticomedullary, nephrographic, and excretory phases images). A total of 14 models were developed, and 7 pairwise comparisons were performed between the 3D V-Net and U-Net models. Segmentation performance was evaluated using Dice similarity coefficient (DSC) and Hausdorff distance (HD), with subgroup analysis of small cCRMs (≤40 mm).
RESULTS: In the test set, the excretory-phase V-Net (EPV-Net model) showed the highest DSC, and perform better than the corresponding U-Net (EPU-Net model) across all cCRMs (DSC: 0.74 ± 0.05 vs 0.70 ± 0.06, P < .001; HD: 27.41 ± 7.44 mm vs 39.18 ± 11.07 mm, P < .001) and the 35 small cCRMs subgroup (DSC: 0.74 ± 0.05 vs 0.70 ± 0.06, P < .001; HD: 27.48 mm ± 6.32 vs 38.72 ± 10.69 mm, P < .001).
CONCLUSIONS: The 3D EPV-Net model demonstrated good segmentation accuracy, even for small lesions, supporting its clinical utility for cCRMs evaluation.
ADVANCES IN KNOWLEDGE: This automated approach may streamline workflow compared to manual segmentation in cCRMs assessment.
METHODS: This multicenter retrospective study analysed 210 cCRMs between October 2019 and May 2021, divided into training/internal validation (n = 150, Institution 1) and test sets (n = 60, Institutions 2-4). Comparative 3D V-Net and U-Net models were developed across 7 MRI sequences (T2-weighted, diffusion-weighted, apparent diffusion coefficient maps, unenhanced T1-weighted, and enhanced corticomedullary, nephrographic, and excretory phases images). A total of 14 models were developed, and 7 pairwise comparisons were performed between the 3D V-Net and U-Net models. Segmentation performance was evaluated using Dice similarity coefficient (DSC) and Hausdorff distance (HD), with subgroup analysis of small cCRMs (≤40 mm).
RESULTS: In the test set, the excretory-phase V-Net (EPV-Net model) showed the highest DSC, and perform better than the corresponding U-Net (EPU-Net model) across all cCRMs (DSC: 0.74 ± 0.05 vs 0.70 ± 0.06, P < .001; HD: 27.41 ± 7.44 mm vs 39.18 ± 11.07 mm, P < .001) and the 35 small cCRMs subgroup (DSC: 0.74 ± 0.05 vs 0.70 ± 0.06, P < .001; HD: 27.48 mm ± 6.32 vs 38.72 ± 10.69 mm, P < .001).
CONCLUSIONS: The 3D EPV-Net model demonstrated good segmentation accuracy, even for small lesions, supporting its clinical utility for cCRMs evaluation.
ADVANCES IN KNOWLEDGE: This automated approach may streamline workflow compared to manual segmentation in cCRMs assessment.